Skip to main content
Clinical Trials/DRKS00010830
DRKS00010830
Not yet recruiting
Not Applicable

Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myeloma - Predict

niversitätsklinikum Freiburg0 sites160 target enrollmentJuly 19, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C90
Sponsor
niversitätsklinikum Freiburg
Enrollment
160
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2016
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Symptomatic, IMiD\-treated MM patients
  • \-MM patients under anti\-myeloma therapy, containing IMiDs (vs. as controls other novel antimyeloma agents)
  • \-Routine bone marrow puncture during MM patient treatment course with IMiDs
  • \-Healthy persons undergoing bone surgery

Exclusion Criteria

  • \-\<18 years of age
  • \-Any kind of health and/or psychological problems which withhold the patient to understand and give his/her written informed consent to use the BM sample for this research project

Outcomes

Primary Outcomes

Not specified

Similar Trials